Earnings Outlook For NeoGenomics

NeoGenomics (NASDAQ:NEO) is set to give its latest quarterly earnings report on Tuesday, 2025-07-29. Here's what investors need to know before the announcement.

Analysts estimate that NeoGenomics will report an earnings per share (EPS) of $-0.01.

Anticipation surrounds NeoGenomics's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Earnings History Snapshot

During the last quarter, the company reported an EPS beat by $0.01, leading to a 2.81% drop in the share price on the subsequent day.

Here's a look at NeoGenomics's past performance and the resulting price change:

Quarter

Q2 2025

Q1 2025

Q4 2024

Q3 2024

Q2 2024

EPS Estimate

-0.01

-0.01

0.03

0.01

0

EPS Actual

0.03

0

0.04

0.05

0.03

Price Change %

-3.0%

-3.0%

3.0%

4.0%

18.0%

Tracking NeoGenomics's Stock Performance

Shares of NeoGenomics were trading at $5.8 as of August 08. Over the last 52-week period, shares are down 65.08%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

Analyst Insights on NeoGenomics

Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on NeoGenomics.

With 3 analyst ratings, NeoGenomics has a consensus rating of Buy. The average one-year price target is $9.0, indicating a potential 55.17% upside.

Analyzing Analyst Ratings Among Peers

This comparison focuses on the analyst ratings and average 1-year ...